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PASSIFLORA – SOURCE OF SANOGENIC COMPOUNDS, 
PROSPECTS FOR MEDICINE AND CURRENT USES 
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Abstract. Passiflora genus includes over 500 species, being the most spread of 
tropical flora. Originally from South America, with more than 60 edible species, 
Passiflora genus presents more and more interest among researchers. The 
passion fruit is remarked by a high content of vitamins, polyphenols and 
carotenoids, antioxidants and anticancer substances (have been identified 13 
types of carotenoids, including beta-, zeta- and alpha-carotene, b-
cryptoxanthin, lycopene). The researchers demonstrated the antioxidant and 
antibacterial activities of leaves and stems of Passiflora quadrangularis, 
Passiflora caerulea and Passiflora edulis. Passiflora incarnata species has 
been extensively studied due to its high content of active substances, which has 
been reported as antispasmodic, sedative and analgesic use. Concidering the 
available biochemical data and the recording of sanogenic effects of the 
Passiflora genus, it is intended to increase the popularity of these species in 
order to raise their interest for acclimatization and cultivation in Romania. 
Key words: ornamental plants, Passiflora species, medicine, bioactive 
compounds 
 
Rezumat. Genul Passiflora cuprinde peste 500 de specii, fiind cel mai răspândit din 
flora tropicală. Originar din America de Sud, cu peste 60 de specii comestibile, 
genul Passiflora prezintă tot mai mult interes în rândul cercetătorilor. Fructul 
pasiunii se remarcă printr-un conţinut ridicat de vitamine, polifenoli şi carotenoizi, 
substanţe antioxidante şi anticancerigene (fiind identificate 13 tipuri de carotenoizi 
dintre care beta-, zeta- şi alpha-caroten, b-cryptoxanthin, lycopen). Cercetătorii au 
demonstrat activităţile antioxidante şi antibacteriene ale frunzelor şi tulpinilor de 
Passiflora quadrangularis, Passiflora caerulea şi Passiflora edulis. Specia 
Passiflora incarnata a fost amplu studiată datorită conţinutului ridicat în substanţe 
active, consemnându-se întrebuinţările sale ca antispasmodic, sedativ şi analgezic. 
Având în vedere datele biochimice disponibile şi consemnarea efectelor sanogene 
ale genului Passiflora, se urmăreşte creşterea popularităţii acestor specii pentru a 
spori interesul în vederea aclimatizării şi cultivării lor în România. 
Cuvinte cheie: plante ornamentale, specii de Passiflora, medicină, compuşi 
bioactivi 
INTRODUCTION 
Plants are a source of bioactive compounds, food and human health being 
closely related to the presence of plants. Since ancient times, plant material is 
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important for man's survival. The plant kingdom is the main supplier of chemical 
compounds used in food, pharmaceutical, cosmetic or agrochemical industries 
with significant economic value. 
The Passiflora genus belongs to the Passifloraceae family, the largest of 
tropical plants, comprising over 500 species, and the genus is the most 
widespread of tropical flora. More than 350 species of the Passifloraceae family 
were found in tropical regions and tropical rainforests in South America, and 60 
of them are edible (Patil, 2013). In addition to the decorative role of the Passiflora 
creepers, the sanogenic effects of these plants were first discovered in Peru, where 
the Spanish doctor Monardes, brought it to Europe in 1569. The Passiflora aerial 
parts were the most popular ingredients incorporated in most sedative extracts, 
tablets and sedatives. Infusion from plant leaves was used in North America in the 
mid-1800s. In many countries in Europe, America and Canada have been used as 
tranquilizers for neurosis for more than 200 years. Passiflora was first registered 
as an official medicine in the 1970s and 1990s by pharmacopoeias in America, 
Great Britain, Germany, France, Switzerland, Egypt and India. For example, in 
Germany, as early as 1979, there were 42 sedatives and six cardiotonics prepared 
from derivatives of this species. It has also been used to treat colic, dysentery, 
diarrhea, menstrual pain, insomnia, headache, eye pain, epilepsy and convulsions 
in pain or muscle spasms (Mowrey, 1986; Tyler 1994; Gontijo Silva, 2000). 
Among the bioactive compounds that may be present in Passiflora leaves are 
counting alkaloids, saponins, cyanogen compounds, and mainly phenolic 
compounds. The passion fruit is appreciated for taste and aroma, but it is an 
important source of nutrients such as carbohydrates, flavonoids, alkaloids, ascorbic 
acid, carotenoids, vitamins, minerals and terpenoids. More than 200 components of 
passion fruit flavors have been described (Gisláine C. Silva et al., 2014). 
MATERIAL AND METHOD 
Passiflora quadrangularis (fig. 1) is a decorative vine appreciated for the great 
flowers, and especially for its tasty fruits. This species produces the biggest fruit of the 
Passifloraceae. The Passiflora quadrangularis extract is used in Caribbean to treat 
headaches or as sedative. Leaf tea is used to treat high blood pressure and diabetes 
(Dhawan et al., 2004). 
           
               Fig. 1 Passiflora quadrangularis                    Fig. 2 Passiflora edulis 
                 (www.chilternseeds.co.uk)                        (https://en.wikipedia.org) 
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Passiflora edulis (fig. 2.) is recognized and cultivated for its edible fruits and for 
its decorative impact. The traditional use of P. edulis for its sedative properties is well 
known in South America, particularly in Brazilian traditional medicine. Such a 
traditional use is based on the utilization of leaves and roots. Fruits are also highly 
appreciated and use against stomach cancer, considered as a digestive stimulant, 
against constipation and as a remedy against gastric carcinoma. Also, P. edulis has 
anthelmintic, diuretic, sedative properties, is used against colic sugars and in 
menopausal symptoms (Chopra et al., 1956, Watt et al., 1962, Hartwell, 1970; Kirtikar et 
al.; Mowrey, 1993). 
Passiflora incarnata (fig. 3) has been recommended since the beginning of the 
century against insomnia and nerve manifestations during menopause. Its aerial parts 
(flowers, fruits and stems) have been used in traditionally medicine (in the USA) against 
anxiety and neuralgia (Brasseur et al., 1984; Leclerc, 1920 cited by Gontijo Silva, 2000). P. 
incarnata is cultivated in Europe and widely used in homeopathy and phytotherapy. 
Since this species has a slightly sedative effect, it can be used in combination with other 
species of the same type of effect, such as Valeriana officinalis, Humulus lupulus and 
Piscidia piscipula for the treatment of insomnia (Rehwald et al., 1995 cited by Gontijo 
Silva, 2000). In addition to these uses, it was also considered beneficial against 
headaches and blood pressure (Ody, 1996).  
Passiflora caerulea (fig. 4) is especially appreciated for its ornamental value, its 
fruits are traditionally used as sedatives and anxiolytics. In India, Netherlands and South 
America the root was used as sedative and vermifug, and in Italy as antispasmodic and 
sedative (Kirtikar et al., 1975; Hickey et al., 1988 cited by Dhawan et al., 2004). 
           
              Fig. 3 Passiflora incarnata                              Fig. 4 Passiflora caerulea 
                (https://en.wikipedia.org)                                 (http://en.hortipedia.com) 
RESULTS AND DISCUSSIONS 
Bioactive compounds. The Passiflora genus has been deeply investigated 
to determine bioactive substances. The chemical content of the species is not yet 
well established. Researchers are trying to differentiate if its sedative effects are 
due to hallucinogenic alcaloids such as harmin and harmalin, or flavonoids such 
as apigenin, luteolin or scopolentin (Tiwari et al., 2016). Phytochemical analyzes 
highlighted the content of alkaloids, phenols, cyanogenic compounds and 
flavonoid glycosydes of P. edulis and P. incarnata. Passicol is a substance with 
antifungal and antimicrobial action, found in Passiflora leaves, produced in a 
higher rate when living tissue is injured (Nicolls, 1973). 
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 Flavonoids are the main bioactive compounds of Passifloraceae. From 
their category are part of apigenin, luteolin, C-glycosyl flavonoids, kaempferol, 
quercetin, vitexin, isovitexin, orientin and isorientin. The largest quantities of 
flavonoids have been found in leaves between pre-flowering and the flowering 
stages of the plant (Dhawan et al., 2004; Ingale et al., 2010). 
 Glycosides are basic compounds of P. edulis. Passiflorins are the main 
glycosidic compounds active in this species, including luteolin-6-C-quinovoside, 
luteolin-6-C-fucoside, cyanophedinoid cyanohydrin glycosides, passicapsin, 
pasibiflorin, epipasicoracin and epithephilin (Seigler et al., 1989; Olafsdottir et al., 1989; 
Mareck et al., 1991 cited by Dhawan et al., 2004). One of the six isolated alkaloids of P. 
incarnata is called "passiflorine", a chemical compound considered by some 
researchers the active compound of the planet (Tiwari et al., 2016). 
 Chrysin is a natural flavor extracted from P. caerulea acting as an 
aromatase inhibitor, administered to cultures and athletes as a dietary supplement. 
The inhibitory effect of chrysin on mammary carcinoma cells, thyroid cancer cells 
and prostate tumors has also been reported (Yin et al., 1999, Knowles et al., 2000, Yin 
et al., 2001 cited by Ingale et al., 2010). 
Therapeutical properties. Passiflora extracts are used in the 
pharmaceutical, food, or cosmetic industries. Traditional medicine plays an 
important role in the treatment of affections suffered by man, so that the 
population relies on traditional and plant-based medicines to 80%, according to 
The World Health Organization. 
 Generalized anxiety may occur with twice the incidence in women than 
in males and up to 9% of the population. The Passiflora extract can improve the 
benzodiazepine concentration for generalized anxiety management. Passion 
flower tincture has anxiolytic effects. Passiflora treatment improves the control of 
emotions, diminishes irritability, and favors a calm state, so it can also be used to 
treat furies from panic attacks (Coleta et al., 2006). 
 Hypertension and cardiovascular disease remain the main cause of 
morbidity and mortality worldwide. P. edulis has been reported for its 
antihypertensive effects. The methanol or luteolin extracts from this plant has 
significantly lowers blood pressure by oral administration. Passiflora reduces the 
predisposition to infarction by almost 40%. Moreover, in combination with 
Crataegus spp., Passiflora increases effort, relieves breathing and improves the 
quality of cardiac life (Ichimura et al., 2006). 
 Antimicrobial activity of Passifloraceae may be an important step in the 
development of medicine. The identification or development of new antimicrobial 
substances is one of the priority directions for the elimination of antibiotic 
resistance situations. Passicol is a chemical component of Passiflora with 
antimicrobial properties. The extracts from passion flower leaves (with ethanol 
and acetone) against human pathogenic bacteria (Pseudomonas putida, Vibrio 
cholerae, Shigella flexneri and Streptococcus pyogenes) were tested by agar 
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inoculation. The results demonstrated remarkable activity against all bacterial 
pathogens (Mohanasundari et al., 2007). The antifungal activity of extracts of P. 
caerulea and P. edulis on the mycelium of Candida albicans and Cryptococcus 
neoformans was tested to demonstrate the inhibition of germination and micellar 
growth of the fungus (Nicolls, 1973). 
CONCLUSIONS 
The Passiflora genus is known on a large area at world level being highly 
appreciated for the gardens and terraces decoration, but also growing in pots for 
bright and spacious interiors. Numerous studies have demonstrated the use of the 
species in antimicrobial, cardiac or neurodegenerative treatments. Various types 
of extracts have been found to have compounds with a broad spectrum of action 
on certain organs, biochemical processes or physiological functions. At the level 
of Romania, the Passiflora genus is not sufficiently studied, but the potential 
culture and valorification of this plant would be high, both of the ornamental 
value and the therapeutic properties. Therefore, studies can be carried out on the 
acclimatization of Passiflora in Romania, as well as supplementing the research 
on the sanogenic potential and medicinal impact. 
REFERENCES 
1. Brasseur T., L. Angenot, 1984 - Contribution a l'etude pharmacognostique de la passifiore. 
Journal de Pharmacologie BeIge 39(1), p. 15. 
2. Chopra R.N., Nayar S.L., Chopra I.C., 1956 - Glossary of Indian Medicinal Plants. CSIR, 
New Delhi, India, p. 186–187. 
3. Coleta M., Batista M.T., Campos M.G., Carvalho R., Cotrim M.D., Lima T.C., A.P. Cunha, 
2006 - Neuropharmacological evaluation of the putative anxiolytic effects of Passiflora 
edulis Sims its sub-fractions and flavonoid constituents. Phytother. Res., 20(12), p. 1067-
1073. 
4. Dhawan K., S. Dhawan, A. Sharma, 2004 - Passiflora: A review update. Journal of 
Ethnopharmacology, nr. 94, p. 1–23. 
5. Gontijo Silva Cláuda, 2000 - Tissue culture and phytochemical studies of Podophyllum, 
Diphylleia and Passiflora species. PhD thesis, University of Nottingham, p. 21, 23. 
6. Hartwell J.L., 1967 - Plants used against cancer: a survey. Lloydia 30(4), p. 379-436. 
7. Hickey M., King C., 1988 - 100 Families of Flowering Plants. Cambridge University Press, 
Cambridge, p.130–133. 
8. Ichimura T., Yamanaka A., Ichiba T., Toyokawa T., Kamada Y., Tamamura T., 
Maruyama S., 2006 - Antihypersensitive effect of an extract of Passiflora edulis rind in 
spontaneously hypersensitive rat. Biosci.Biotechnol. Biochem., 70-3, p. 718-721. 
9. Ingale A.G.,  A.U. Hivrale, 2010 - Pharmacological studies of Passiflora sp. and their 
bioactive compounds. African Journal of Plant Science Vol. 4(10), p. 417-426. 
10. Kirtikar K.R., Basu B.D., 1975 - Indian Medicinal Plants. Periodical Experts, Dehradun, 
India, p. 1103. 
11. Knowles L.M., Zigrossi D.A., Tauber R.A., Hightower C., Milner J.A., 2000 - Flavonoids 
suppress androgen-independant human prostate tumor proliferation. Nutr. Cancer, 38-1, 
p. 116-122. 
12. Leclerc H., 1920 - Note sur Ie traitement de l'insomnie consecutive a la grippe par la 
passiflore. Bulletin des Sciences Pharmacologiques 27, p. 548-553. 
LUCRĂRI ŞTIINŢIFICE SERIA HORTICULTURĂ, 60 (2) / 2017, USAMV IAŞI 
274 
13. Mareck U., Herrmann K., Galensa R., Wray V., 1991 - The 6-Cchinovoside and 6-C-
fucoside of luteolin from Passiflora edulis. Phytochemistry 30, p. 3486–3487. 
14. Mohanasundari C., Natarajan D., Srinivasan K., Umamaheswari S., Ramachandran A. 
2007 - Antibacterial properties of Passiflora foetida L. a common exotic medicinal plant. 
Afr. J. Biotechnol., 6-23, p. 2650-2653. 
15. Mowrey D.B., 1993 - Herbal Tonic Therapies. Keats Publ. Incorporation, New Canaan, CT. 
16. Mowrey D.B. 1986 - The Scientific Validation of Herbal Medicine. Keats Publishing, 
NewCanaan, p. 316.  
17. Nicolls J.M., J. Birner, P. Forsell, 1973 - Passicol, an Antibacterial and Antifungal Agent 
Produced by Passiflora Plant Species: Qualitative and Quantitative Range of Activity.  
American Society for Microbiology, Vol. 3, No. 1, USA p. 110-117. 
18. Nicolls J.M., J. Birner, 1973 - Passicol, an Antibacterial and Antifungal Agent Produced by 
Passiflora Plant Species: Preparation and Physicochemical Characteristics. American 
Society for Microbiology, Vol. 3, No. 1, USA, p. 105-109. 
19. Ody P., 1996 - Handbook of Over-the-Counter Herbal Medicines. Kyle Cathie Ltd., London. 
p. 446. 
20. Olafsdottir E.S., Andersen J.V., Jaroszewski J.W., 1989-Cyclopentenoid cyanohydrin 
glycosides. Part 9. Cyanohydrin glycosides of Passifloraceae. Phytochemistry 28, p. 127–
132. 
21. Patil A.S., H.M. Paikaro, S.R. Patil, 2013 - Passiflora foetida linn: a complete 
morphological and phytopharmacological review. International Journal of Pharma and 
Bio Sciences, USA, p. 286.  
22. Rehwald A., O. Stieher, B. Meier, 1995 - Trace analysis of hannan alkaloids in Passiflora 
incarnata by reversed-phase high perfonnance liquid chromatography. Phytochemical 
Analysis 6, p. 96-100. 
23. Seigler D.S., Spencer K.C., 1989 - Corrected structures of passicoriacin,  pipassicoriacin 
and epitetraphyllin B and their distriubution in the Flacourtiaceae and Passifloraceae. 
Phytochemistry 28, p. 931–932. 
24. Silva C. Gisláine, Carla B.G. Bottoli, 2014 - Analyses of Passiflora compounds by 
chromatographic and electrophoretic technique.  Critical Reviews in Analytical 
Chemistry, London. 
25. Tiwari S., S. Singh, S. Tripathi, S. Kumar, 2016 - A pharmacological review: Passiflora 
species. IJP Vol. 3(1) p. 10-18. 
26. Tyler E.V., 1994 - Nervous system disorders, Smith MC (ed.). Herbs of Choice: The 
Therapeutic Use of Phytomedicinals, Pharmaceutical Products Press, Binghamton, New 
York, p. 117-134.  
27. Watt J.M., Breyer-Brandwijk M.G., 1962 - The Medicinal and Poisonous Plants of 
Southern and Eastern Africa. Edinburg, Livingston, p. 826–830. 
28. Yin F., Giuliano A.E., Law R.E., Van Herie A.J., 2001 - Apigenin inhibits growth and 
induces G2/M arrest by modulating cyclin CDK regulators and ERK MAP kinase 
activation in breast carcinoma cells. Anticancer Res., 21-1A, p. 413-420. 
29. Yin F., Giuliano A.E, Van Hearle A.J., 1999 - Growth inhibitory effects of flavonoids in 
human thyroid cancer cell lines. Thyroid, 9(4), p. 369-376. 
30. ***, https://www.chilternseeds.co.uk/item_960c_passiflora_quadrangularis_seeds 
31. ***, http://en.hortipedia.com/wiki/Passiflora_caerulea 
32. ***, https://en.wikipedia.org/wiki/Passiflora_edulis 
33. ***, https://en.wikipedia.org/wiki/Passiflora_incarnata 
